Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Preclinical anticonvulsant and neuroprotective profile of 8319, a non-competitive NMDA antagonist

Journal Article · · Progress in Clinical and Biological Research; (USA)
OSTI ID:5659738

8319, ((+-)-2-Amino-N-ethyl-alpha- (3-methyl-2-thienyl) benzeneethanamine 2HCl), is a novel compound with the profile of a non-competitive NMDA antagonist. The compound displaced (3H) TCP with high affinity (IC50 = 43 nM), but was inactive at the NMDA, benzodiazepine and GABA sites; in vivo, 8319 showed good efficacy as an anticonvulsant and potential neuroprotective agent. It blocked seizures induced by NMDLA, supramaximal electroshock, pentylenetetrazol (PTZ), picrotoxin, and thiosemicarbazide with ED50's of 1-20 mg/kg ip. As a neuroprotective agent, 8319 (30-100 mg/kg sc) prevented the death of dorsal hippocampal pyramidal cells induced by direct injection of 20 nmol NMDA. At 15 mg/kg ip, the compound was also effective against hippocampal neuronal necrosis induced via bilateral occlusion of the carotid arteries in gerbils. In summary, 8319 is a noncompetitive NMDA antagonist with good anticonvulsant activity and may possess neuroprotective properties useful in the treatment of brain ischemia.

OSTI ID:
5659738
Journal Information:
Progress in Clinical and Biological Research; (USA), Journal Name: Progress in Clinical and Biological Research; (USA) Vol. 361; ISSN PCBRD; ISSN 0361-7742
Country of Publication:
United States
Language:
English